Mycoplasma Testing Market 2028 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

    Mycoplasma Testing Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product & Service (Kits & Reagents, Instruments and Services); Application (Cell Line Testing, Virus Testing, End-Of-Production Cell Testing and Other Applications); End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Other End Users), and Geography

    Report Code: TIPRE00003516 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

    MARKET INTRODUCTION


    Testing for mycoplasma contamination is an essential practice in the process of cell culturing. Mycoplasma are small, simple bacteria, they represent one of the most prevalent and serious sources of cell line contamination. Since, these organisms lack a cell wall, they have a rapid mode of infecting the entire cell culture, causing loss on a large scale. Hence, in order to obtain better results, various companies have been providing solutions for testing mycoplasma contamination.

    MARKET DYNAMICS


    The mycoplasma testing market is anticipated to grow in the forecast, owing to increasing support and growth opportunity provided by biotechnology as well as the pharmaceutical industry, along with strong R&D investments in life sciences. In addition, increasing pharmaceutical outsourcing is expected to offer significant growth opportunities in the market during the forecast period.

    MARKET SCOPE


    The "Global Mycoplasma Testing Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of mycoplasma testing market with detailed market segmentation by product & services, application, end user, and geography. The global mycoplasma testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading mycoplasma testing market players and offers key trends and opportunities in the market.

    MARKET SEGMENTATION


    The global mycoplasma testing market is segmented on the basis of product & services, application and end user. Based on product & services, the market is segmented as kits & reagents, instruments and services. On the basis of application, the global mycoplasma testing market is segmented into, cell line testing, virus testing, end-of-production cell testing and other applications. Similarly, based on end user, the market is categorized as, pharmaceutical and biotechnology companies, contract research organizations, academic research institutes and other end users

    Get more information on this report :


    REGIONAL FRAMEWORK


    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global mycoplasma testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The mycoplasma testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

    The report analyzes factors affecting mycoplasma testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the mycoplasma testing market in these regions.

    Get more information on this report :

    MARKET PLAYERS


    The reports cover key developments in the mycoplasma testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from mycoplasma testing market are anticipated to lucrative growth opportunities in the future with the rising demand for mycoplasma testing market in the global market. Below mentioned is the list of few companies engaged in the mycoplasma testing market.

    The report also includes the profiles of key mycoplasma testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
    • Agilent Technologies, Inc.
    • Charles River
    • Eurofins Scientific
    • F. Hoffmann-La Roche Ltd
    • Lonza
    • Merck KGaA
    • Minerva Biolabs
    • Sartorius AG
    • SGS SA
    • Thermo Fisher Scientific Inc.
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

    Get more information on this report :

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Mycoplasma Testing Market - By Product & Service
    1.3.2 Mycoplasma Testing Market - By Application
    1.3.3 Mycoplasma Testing Market - By End User
    1.3.4 Mycoplasma Testing Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEWAYS
    3. RESEARCH METHODOLOGY
    4. MYCOPLASMA TESTING MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. MYCOPLASMA TESTING MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
    6. MYCOPLASMA TESTING MARKET - GLOBAL MARKET ANALYSIS
    6.1. MYCOPLASMA TESTING - GLOBAL MARKET OVERVIEW
    6.2. MYCOPLASMA TESTING - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE
    7. MYCOPLASMA TESTING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT & SERVICE
    7.1. OVERVIEW
    7.2. PRODUCT & SERVICE MARKET FORECASTS AND ANALYSIS
    7.3. KITS & REAGENTS
    7.3.1. Overview
    7.3.2. Kits & Reagents Market Forecast and Analysis
    7.4. INSTRUMENTS
    7.4.1. Overview
    7.4.2. Instruments Market Forecast and Analysis
    7.5. SERVICES
    7.5.1. Overview
    7.5.2. Services Market Forecast and Analysis
    8. MYCOPLASMA TESTING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    8.1. OVERVIEW
    8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    8.3. CELL LINE TESTING
    8.3.1. Overview
    8.3.2. Cell Line Testing Market Forecast and Analysis
    8.4. VIRUS TESTING
    8.4.1. Overview
    8.4.2. Virus Testing Market Forecast and Analysis
    8.5. END-OF-PRODUCTION CELL TESTING
    8.5.1. Overview
    8.5.2. End-Of-Production Cell Testing Market Forecast and Analysis
    8.6. OTHER APPLICATIONS
    8.6.1. Overview
    8.6.2. Other Applications Market Forecast and Analysis
    9. MYCOPLASMA TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
    9.1. OVERVIEW
    9.2. END USER MARKET FORECASTS AND ANALYSIS
    9.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    9.3.1. Overview
    9.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
    9.4. CONTRACT RESEARCH ORGANIZATIONS
    9.4.1. Overview
    9.4.2. Contract Research Organizations Market Forecast and Analysis
    9.5. ACADEMIC RESEARCH INSTITUTES
    9.5.1. Overview
    9.5.2. Academic Research Institutes Market Forecast and Analysis
    9.6. OTHER END USERS
    9.6.1. Overview
    9.6.2. Other End Users Market Forecast and Analysis
    10. MYCOPLASMA TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Mycoplasma Testing Market Overview
    10.1.2 North America Mycoplasma Testing Market Forecasts and Analysis
    10.1.3 North America Mycoplasma Testing Market Forecasts and Analysis - By Product & Service
    10.1.4 North America Mycoplasma Testing Market Forecasts and Analysis - By Application
    10.1.5 North America Mycoplasma Testing Market Forecasts and Analysis - By End User
    10.1.6 North America Mycoplasma Testing Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Mycoplasma Testing Market
    10.1.6.1.1 United States Mycoplasma Testing Market by Product & Service
    10.1.6.1.2 United States Mycoplasma Testing Market by Application
    10.1.6.1.3 United States Mycoplasma Testing Market by End User
    10.1.6.2 Canada Mycoplasma Testing Market
    10.1.6.2.1 Canada Mycoplasma Testing Market by Product & Service
    10.1.6.2.2 Canada Mycoplasma Testing Market by Application
    10.1.6.2.3 Canada Mycoplasma Testing Market by End User
    10.1.6.3 Mexico Mycoplasma Testing Market
    10.1.6.3.1 Mexico Mycoplasma Testing Market by Product & Service
    10.1.6.3.2 Mexico Mycoplasma Testing Market by Application
    10.1.6.3.3 Mexico Mycoplasma Testing Market by End User
    10.2. EUROPE
    10.2.1 Europe Mycoplasma Testing Market Overview
    10.2.2 Europe Mycoplasma Testing Market Forecasts and Analysis
    10.2.3 Europe Mycoplasma Testing Market Forecasts and Analysis - By Product & Service
    10.2.4 Europe Mycoplasma Testing Market Forecasts and Analysis - By Application
    10.2.5 Europe Mycoplasma Testing Market Forecasts and Analysis - By End User
    10.2.6 Europe Mycoplasma Testing Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Mycoplasma Testing Market
    10.2.6.1.1 Germany Mycoplasma Testing Market by Product & Service
    10.2.6.1.2 Germany Mycoplasma Testing Market by Application
    10.2.6.1.3 Germany Mycoplasma Testing Market by End User
    10.2.6.2 France Mycoplasma Testing Market
    10.2.6.2.1 France Mycoplasma Testing Market by Product & Service
    10.2.6.2.2 France Mycoplasma Testing Market by Application
    10.2.6.2.3 France Mycoplasma Testing Market by End User
    10.2.6.3 Italy Mycoplasma Testing Market
    10.2.6.3.1 Italy Mycoplasma Testing Market by Product & Service
    10.2.6.3.2 Italy Mycoplasma Testing Market by Application
    10.2.6.3.3 Italy Mycoplasma Testing Market by End User
    10.2.6.4 Spain Mycoplasma Testing Market
    10.2.6.4.1 Spain Mycoplasma Testing Market by Product & Service
    10.2.6.4.2 Spain Mycoplasma Testing Market by Application
    10.2.6.4.3 Spain Mycoplasma Testing Market by End User
    10.2.6.5 United Kingdom Mycoplasma Testing Market
    10.2.6.5.1 United Kingdom Mycoplasma Testing Market by Product & Service
    10.2.6.5.2 United Kingdom Mycoplasma Testing Market by Application
    10.2.6.5.3 United Kingdom Mycoplasma Testing Market by End User
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Mycoplasma Testing Market Overview
    10.3.2 Asia-Pacific Mycoplasma Testing Market Forecasts and Analysis
    10.3.3 Asia-Pacific Mycoplasma Testing Market Forecasts and Analysis - By Product & Service
    10.3.4 Asia-Pacific Mycoplasma Testing Market Forecasts and Analysis - By Application
    10.3.5 Asia-Pacific Mycoplasma Testing Market Forecasts and Analysis - By End User
    10.3.6 Asia-Pacific Mycoplasma Testing Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Mycoplasma Testing Market
    10.3.6.1.1 Australia Mycoplasma Testing Market by Product & Service
    10.3.6.1.2 Australia Mycoplasma Testing Market by Application
    10.3.6.1.3 Australia Mycoplasma Testing Market by End User
    10.3.6.2 China Mycoplasma Testing Market
    10.3.6.2.1 China Mycoplasma Testing Market by Product & Service
    10.3.6.2.2 China Mycoplasma Testing Market by Application
    10.3.6.2.3 China Mycoplasma Testing Market by End User
    10.3.6.3 India Mycoplasma Testing Market
    10.3.6.3.1 India Mycoplasma Testing Market by Product & Service
    10.3.6.3.2 India Mycoplasma Testing Market by Application
    10.3.6.3.3 India Mycoplasma Testing Market by End User
    10.3.6.4 Japan Mycoplasma Testing Market
    10.3.6.4.1 Japan Mycoplasma Testing Market by Product & Service
    10.3.6.4.2 Japan Mycoplasma Testing Market by Application
    10.3.6.4.3 Japan Mycoplasma Testing Market by End User
    10.3.6.5 South Korea Mycoplasma Testing Market
    10.3.6.5.1 South Korea Mycoplasma Testing Market by Product & Service
    10.3.6.5.2 South Korea Mycoplasma Testing Market by Application
    10.3.6.5.3 South Korea Mycoplasma Testing Market by End User
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Mycoplasma Testing Market Overview
    10.4.2 Middle East and Africa Mycoplasma Testing Market Forecasts and Analysis
    10.4.3 Middle East and Africa Mycoplasma Testing Market Forecasts and Analysis - By Product & Service
    10.4.4 Middle East and Africa Mycoplasma Testing Market Forecasts and Analysis - By Application
    10.4.5 Middle East and Africa Mycoplasma Testing Market Forecasts and Analysis - By End User
    10.4.6 Middle East and Africa Mycoplasma Testing Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Mycoplasma Testing Market
    10.4.6.1.1 South Africa Mycoplasma Testing Market by Product & Service
    10.4.6.1.2 South Africa Mycoplasma Testing Market by Application
    10.4.6.1.3 South Africa Mycoplasma Testing Market by End User
    10.4.6.2 Saudi Arabia Mycoplasma Testing Market
    10.4.6.2.1 Saudi Arabia Mycoplasma Testing Market by Product & Service
    10.4.6.2.2 Saudi Arabia Mycoplasma Testing Market by Application
    10.4.6.2.3 Saudi Arabia Mycoplasma Testing Market by End User
    10.4.6.3 U.A.E Mycoplasma Testing Market
    10.4.6.3.1 U.A.E Mycoplasma Testing Market by Product & Service
    10.4.6.3.2 U.A.E Mycoplasma Testing Market by Application
    10.4.6.3.3 U.A.E Mycoplasma Testing Market by End User
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Mycoplasma Testing Market Overview
    10.5.2 South and Central America Mycoplasma Testing Market Forecasts and Analysis
    10.5.3 South and Central America Mycoplasma Testing Market Forecasts and Analysis - By Product & Service
    10.5.4 South and Central America Mycoplasma Testing Market Forecasts and Analysis - By Application
    10.5.5 South and Central America Mycoplasma Testing Market Forecasts and Analysis - By End User
    10.5.6 South and Central America Mycoplasma Testing Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Mycoplasma Testing Market
    10.5.6.1.1 Brazil Mycoplasma Testing Market by Product & Service
    10.5.6.1.2 Brazil Mycoplasma Testing Market by Application
    10.5.6.1.3 Brazil Mycoplasma Testing Market by End User
    10.5.6.2 Argentina Mycoplasma Testing Market
    10.5.6.2.1 Argentina Mycoplasma Testing Market by Product & Service
    10.5.6.2.2 Argentina Mycoplasma Testing Market by Application
    10.5.6.2.3 Argentina Mycoplasma Testing Market by End User
    11. INDUSTRY LANDSCAPE
    11.1. MERGERS AND ACQUISITIONS
    11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    11.3. NEW PRODUCT LAUNCHES
    11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    12. MYCOPLASMA TESTING MARKET, KEY COMPANY PROFILES
    12.1. AGILENT TECHNOLOGIES, INC.
    12.1.1. Key Facts
    12.1.2. Business Description
    12.1.3. Products and Services
    12.1.4. Financial Overview
    12.1.5. SWOT Analysis
    12.1.6. Key Developments
    12.2. CHARLES RIVER
    12.2.1. Key Facts
    12.2.2. Business Description
    12.2.3. Products and Services
    12.2.4. Financial Overview
    12.2.5. SWOT Analysis
    12.2.6. Key Developments
    12.3. EUROFINS SCIENTIFIC
    12.3.1. Key Facts
    12.3.2. Business Description
    12.3.3. Products and Services
    12.3.4. Financial Overview
    12.3.5. SWOT Analysis
    12.3.6. Key Developments
    12.4. F. HOFFMANN-LA ROCHE LTD
    12.4.1. Key Facts
    12.4.2. Business Description
    12.4.3. Products and Services
    12.4.4. Financial Overview
    12.4.5. SWOT Analysis
    12.4.6. Key Developments
    12.5. LONZA
    12.5.1. Key Facts
    12.5.2. Business Description
    12.5.3. Products and Services
    12.5.4. Financial Overview
    12.5.5. SWOT Analysis
    12.5.6. Key Developments
    12.6. MERCK KGAA
    12.6.1. Key Facts
    12.6.2. Business Description
    12.6.3. Products and Services
    12.6.4. Financial Overview
    12.6.5. SWOT Analysis
    12.6.6. Key Developments
    12.7. MINERVA BIOLABS
    12.7.1. Key Facts
    12.7.2. Business Description
    12.7.3. Products and Services
    12.7.4. Financial Overview
    12.7.5. SWOT Analysis
    12.7.6. Key Developments
    12.8. SARTORIUS AG
    12.8.1. Key Facts
    12.8.2. Business Description
    12.8.3. Products and Services
    12.8.4. Financial Overview
    12.8.5. SWOT Analysis
    12.8.6. Key Developments
    12.9. SGS SA
    12.9.1. Key Facts
    12.9.2. Business Description
    12.9.3. Products and Services
    12.9.4. Financial Overview
    12.9.5. SWOT Analysis
    12.9.6. Key Developments
    12.10. THERMO FISHER SCIENTIFIC INC.
    12.10.1. Key Facts
    12.10.2. Business Description
    12.10.3. Products and Services
    12.10.4. Financial Overview
    12.10.5. SWOT Analysis
    12.10.6. Key Developments
    13. APPENDIX
    13.1. ABOUT THE INSIGHT PARTNERS
    13.2. GLOSSARY OF TERMS
    The List of Companies

    1. Agilent Technologies, Inc.
    2. Charles River
    3. Eurofins Scientific
    4. F. Hoffmann-La Roche Ltd
    5. Lonza
    6. Merck KGaA
    7. Minerva Biolabs
    8. Sartorius AG
    9. SGS SA
    10. Thermo Fisher Scientific Inc.
    TIPRE00003516
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount